ALTERITY THERAPEUTICS LIMITED

Contributing Author

Recent Articles by ALTERITY THERAPEUTICS LIMITED

8 hours	Appendix 4C - Q4 FY25 Quarterly Cash Flow Report ATHE GlobeNewswire
Jul-28	Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy ATHE GlobeNewswire
Jul-24	Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study ATHE GlobeNewswire
Jun-23	Alterity Therapeutics to Provide Corporate Update in Fireside Chat ATHE GlobeNewswire
May-12	Alterity Therapeutics Prominently Featured at the International MSA Congress ATHE GlobeNewswire
May-07	Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress ATHE GlobeNewswire
May-05	Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy ATHE GlobeNewswire